| RS1360284524 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1360293270 |
CACNA1F
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1360295659 |
CYP4F22
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 5, Autosomal recessive congenital ichthyosis 5 |
| RS1360298758 |
SACS
|
Health Risk |
Pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1360308012 |
CAD
|
Health Risk |
Pathogenic |
— |
| RS1360314039 |
RTN4IP1
|
Health Risk |
Likely pathogenic |
— |
| RS1360333956 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal dominant form |
| RS1360336411 |
EGFR
|
Health Risk |
Likely pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS1360362529 |
CYP17A1
|
Health Risk |
Pathogenic |
Deficiency of steroid 17-alpha-monooxygenase, Deficiency of steroid 17-alpha-monooxygenase |
| RS1360367329 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1360371971 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1360382612 |
CFI
|
Health Risk |
Likely pathogenic |
Factor I deficiency, Factor I deficiency |
| RS1360391558 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1360397142 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1360400826 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac valvular dysplasia, X-linked |
| RS1360401833 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1360415315 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 2, Hyperinsulinism due to glucokinase deficiency |
| RS1360415486 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS1360420006 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1360427319 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1360428152 |
SART3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Neurodevelopmental defects and Developmental delay with 46 |
| RS1360446142 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1360462093 |
VPS33B
|
Health Risk |
Pathogenic/Likely pathogenic |
Keratoderma-ichthyosis-deafness syndrome, autosomal recessive |
| RS1360472871 |
HPDL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, Spastic paraplegia |
| RS1360480518 |
CLCN7
|
Health Risk |
Pathogenic |
— |
| RS1360481164 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS1360484422 |
ASNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS1360515765 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, Inborn genetic diseases |
| RS1360531002 |
B3GALT6
|
Health Risk |
Pathogenic |
Al-Gazali syndrome, Al-Gazali syndrome |
| RS1360564195 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1360606073 |
COL4A4
|
Health Risk |
Pathogenic |
Hematuria, benign familial |
| RS1360606629 |
ABCC8
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS1360618530 |
IMPG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 56, Retinitis pigmentosa 56 |
| RS1360625972 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adult hypophosphatasia, Childhood hypophosphatasia |
| RS1360631927 |
ERCC2
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group D |
| RS1360639709 |
PDE6B
|
Health Risk |
Pathogenic |
— |
| RS1360639935 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1360640311 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1360649783 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1360654111 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1360665697 |
UBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Johanson-Blizzard syndrome |
| RS1360689553 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 10, Spastic paraplegia |
| RS1360704374 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, Recessive dystrophic epidermolysis bullosa |
| RS1360711033 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1360721056 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 54 |
| RS1360725610 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1360735193 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1360780 |
FKBP5
|
Health Risk |
Likely risk allele |
Antidepressant drug treatment, accelerated response to |
| RS1360781582 |
ALOX12B
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 2, Autosomal recessive congenital ichthyosis 2 |
| RS1360782538 |
COL9A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1360794165 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 4, Endometrial carcinoma |
| RS1360796756 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1360807330 |
PANK2
|
Health Risk |
Pathogenic |
Pigmentary pallidal degeneration, Pigmentary pallidal degeneration |
| RS1360809225 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS1360829798 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS1360832162 |
CFAP52
|
Health Risk |
Conflicting classifications of pathogenicity |
Situs inversus, Oculomotor apraxia |
| RS1360840874 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1360863995 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1360871464 |
ADAMTS17
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani 4 syndrome, recessive |
| RS1360895808 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1360897161 |
PIEZO2
|
Health Risk |
Likely pathogenic |
— |
| RS1360901964 |
RARS2
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1360902821 |
UBQLN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 15, Amyotrophic lateral sclerosis type 15 |
| RS1360906241 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1360926879 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1360936268 |
FGFR3
|
Health Risk |
Likely pathogenic |
Achondroplasia, Achondroplasia |
| RS1360937549 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1360950889 |
CHST3
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloepiphyseal dysplasia with congenital joint dislocations, Spondyloepiphyseal dysplasia with congenital joint dislocations |
| RS1360965916 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, CDKN1C-related disorder |
| RS1360977917 |
PIGN
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1360979536 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1360984931 |
POGZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1361003749 |
MPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1361024832 |
PATL2
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 4, Oocyte maturation defect 4 |
| RS1361047594 |
NEFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1361062364 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS1361076729 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS1361083258 |
CACNA1E
|
Health Risk |
Likely pathogenic |
— |
| RS1361089796 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1361123068 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1361137530 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1361137766 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS1361155132 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS1361155142 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS1361160803 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1361161166 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1361189290 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS1361197028 |
P4HTM
|
Health Risk |
Pathogenic |
— |
| RS1361215494 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1361221383 |
EPM2A
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Lafora disease |
| RS1361221734 |
GUF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1361233426 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1361255226 |
AMACR
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha-methylacyl-CoA racemase deficiency, Alpha-methylacyl-CoA racemase deficiency |
| RS1361270203 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1361283193 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1361284521 |
CYP17A1
|
Health Risk |
Likely pathogenic |
— |
| RS1361285566 |
NEXN
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 20, Dilated cardiomyopathy 1CC |
| RS1361289668 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1361298317 |
USP9X
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1361324844 |
CBS
|
Health Risk |
Pathogenic |
Homocystinuria, Classic homocystinuria |